Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ceribell, Inc.CBLL · Entity 4994 | Director | June 02, 2026 | June 04, 2026 |
| Lucira Health, Inc.LHDX · Entity 115613 | Director | June 01, 2022 | June 03, 2022 |
| Sight Sciences, Inc.SGHT · Entity 5537 | Director | June 05, 2025 | June 10, 2025 |
| Silk Road Medical IncSILK · Entity 87417 | Director · President and CEO | March 02, 2021 | September 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ceribell, Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,054 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 7,838 · Balance 33,054 F1: Represents restricted stock units ("RSUs"). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs").
Lucira Health, Inc.
Report date June 01, 2022 · Filed June 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2032-05-31 | Direct | 59,459 |
Reported balance
After 2022-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-01 · Grant · Acquired 59,459 · Balance 59,459 F1: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting.
Sight Sciences, Inc.
Report date June 05, 2025 · Filed June 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 175,352 |
Reported balance
After 2025-06-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-05 · Grant · Acquired 30,952 · Balance 175,352 F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $130,000 divided by the closing price of the Common Stock on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2: Includes (i) 44,400 shares of Common Stock, (ii) 30,952 RSUs, which are subject to vesting as reported herein, and (iii) 100,000 shares of Common Stock which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 5, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $130,000 divided by the closing price of the Common Stock on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
F2: Includes (i) 44,400 shares of Common Stock, (ii) 30,952 RSUs, which are subject to vesting as reported herein, and (iii) 100,000 shares of Common Stock which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 5, 2025.
Silk Road Medical Inc
Report date March 02, 2021 · Filed September 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 267,988 |
Reported balance
After 2021-03-02 transaction · row 1
1 source rowRow 1 · 2021-03-02 · Sale · Disposed 1,651 · Balance 267,988 F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on September 11, 2020, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). F2: This transaction was executed in multiple trades at price ranging from $56.55 to $56.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on September 11, 2020, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2: This transaction was executed in multiple trades at price ranging from $56.55 to $56.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 11, 2022 Filed Jul 13, 2022 17:32 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 30,000 | $1.60 | $48,000.00 |
DisclosureSEC source: 0001593968-22-001242 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. Read SEC document |
| June 08, 2022 Filed Aug 5, 2022 20:08 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantRestricted Stock Units · Derivative | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027818 · doc4.xml · derivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:42 UTC | Lucira Health, Inc. LHDX · Entity 115613 | GrantStock Option (right to buy) · Derivative | 59,459 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001209191-22-034104 · doc4.xml · derivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,459 Underlying: Common Stock · 59,459 shares Expires 2032-05-31 F1 · derivative.exercise_date: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting. Read SEC document |
| May 20, 2022 Filed Jul 13, 2022 17:32 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantCommon Stock | 550 | $24.51 | $13,480.50 |
DisclosureSEC source: 0001593968-22-001242 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,199 F3 · kind: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 19:21 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-22-000863 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,654 Underlying: Common Stock · 30,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 19:21 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 30,000 | $43.37 | $1,301,172.00 |
DisclosureSEC source: 0001593968-22-000863 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,649 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F2 · price: This transaction was executed in multiple trades at price ranging from $42.80 to $44.44. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 19:21 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 30,000 | $1.60 | $48,000.00 |
DisclosureSEC source: 0001593968-22-000863 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 18:56 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantOption (right to buy) · Derivative | 162,700 | $0.00 Strike: $36.01 | $0.00 |
DisclosureSEC source: 0001593968-22-000657 · primary_01.xml · derivative · entry 6 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,700 Underlying: Common Stock · 162,700 shares Expires 2032-03-03 F4 · derivative.exercise_date: One forty-eighth of the shares subject to the option shall vest on April 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 18:56 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantOption (right to buy) · Derivative | 85,320 | $0.00 Strike: $36.01 | $0.00 |
DisclosureSEC source: 0001593968-22-000657 · primary_01.xml · derivative · entry 5 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,320 Underlying: Common Stock · 85,320 shares Expires 2032-03-03 F4 · derivative.exercise_date: One forty-eighth of the shares subject to the option shall vest on April 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 18:56 UTC | Silk Road Medical Inc SILK · Entity 87417 | Tax withholdingCommon Stock | 3,100 | $35.72 | $110,735.72 |
DisclosureSEC source: 0001593968-22-000657 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,649 F2 · shares: Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 18:56 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-000657 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,749 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 18:56 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantCommon Stock | 93,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-000657 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,749 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 18:55 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-22-000213 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,654 Underlying: Common Stock · 10,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 18:55 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 10,000 | $41.88 | $418,787.00 |
DisclosureSEC source: 0001593968-22-000213 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,179 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F2 · price: This transaction was executed in multiple trades at price ranging from $40.03 to $42.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 18:55 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 10,000 | $1.60 | $16,000.00 |
DisclosureSEC source: 0001593968-22-000213 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:39 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-002545 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,654 Underlying: Common Stock · 10,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:39 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 10,000 | $40.95 | $409,530.00 |
DisclosureSEC source: 0001593968-21-002545 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,179 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F2 · price: This transaction was executed in multiple trades at price ranging from $40.25 to $41.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:39 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 10,000 | $1.60 | $16,000.00 |
DisclosureSEC source: 0001593968-21-002545 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. Read SEC document |
| November 30, 2021 Filed Nov 30, 2021 19:37 UTC | Silk Road Medical Inc SILK · Entity 87417 | PurchaseCommon Stock | 2,500 | $41.30 | $103,250.00 |
DisclosureSEC source: 0001593968-21-002476 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,179 F1 · price: This transaction was executed in multiple trades at price ranging from $41.22 to $41.31. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-002392 · primary_01.xml · derivative · entry 8 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,654 Underlying: Common Stock · 10,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F5 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 5,738 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001593968-21-002392 · primary_01.xml · derivative · entry 7 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,738 shares Expires 2024-12-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F5 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 2,357 | $50.47 | $118,957.79 |
DisclosureSEC source: 0001593968-21-002392 · primary_01.xml · nonDerivative · entry 5 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,679 F3 · kind: The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 10,000 | $50.64 | $506,394.00 |
DisclosureSEC source: 0001593968-21-002392 · primary_01.xml · nonDerivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,036 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F2 · price: This transaction was executed in multiple trades at price ranging from $49.31 to $51.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 10,000 | $1.60 | $16,000.00 |
DisclosureSEC source: 0001593968-21-002392 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 5,738 | $50.64 | $290,568.88 |
DisclosureSEC source: 0001593968-21-002392 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,036 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. F2 · price: This transaction was executed in multiple trades at price ranging from $49.31 to $51.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 5,738 | $1.46 | $8,377.48 |
DisclosureSEC source: 0001593968-21-002392 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2021. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 20:48 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-002263 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,654 Underlying: Common Stock · 11,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 20:48 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $55.73 | $613,013.50 |
DisclosureSEC source: 0001593968-21-002263 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,036 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $53.98 to $56.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 20:48 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-002263 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 20:23 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-002127 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,654 Underlying: Common Stock · 11,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 20:23 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $57.32 | $630,565.10 |
DisclosureSEC source: 0001593968-21-002127 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,036 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $56.05 to $58.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 20:23 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-002127 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 19:32 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-001970 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,654 Underlying: Common Stock · 11,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 19:32 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $49.12 | $540,317.80 |
DisclosureSEC source: 0001593968-21-001970 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,036 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $48.61 to $49.47. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 19:32 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-001970 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 18:54 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-001839 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,654 Underlying: Common Stock · 11,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 18:54 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $46.25 | $508,774.20 |
DisclosureSEC source: 0001593968-21-001839 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,036 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $45.19 to $47.03. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 18:54 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-001839 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-001613 · primary_01.xml · derivative · entry 5 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,654 Underlying: Common Stock · 11,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F5 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $47.02 | $517,188.10 |
DisclosureSEC source: 0001593968-21-001613 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,616 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $46.64 to $47.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-001613 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| May 20, 2021 Filed Jun 14, 2021 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantCommon Stock | 420 | $40.38 | $16,959.60 |
DisclosureSEC source: 0001593968-21-001613 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,036 F3 · kind: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:38 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-001295 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,654 Underlying: Common Stock · 11,000 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:38 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $48.65 | $535,197.30 |
DisclosureSEC source: 0001593968-21-001295 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,616 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $47.82 to $49.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:38 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-001295 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:02 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 10,605 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-001114 · primary_01.xml · derivative · entry 7 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,654 Underlying: Common Stock · 10,605 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:02 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 395 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-001114 · primary_01.xml · derivative · entry 6 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,467 Underlying: Common Stock · 395 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:02 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 10,605 | $49.73 | $527,422.71 |
DisclosureSEC source: 0001593968-21-001114 · primary_01.xml · nonDerivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,616 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $48.81 to $50.30. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:02 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 10,605 | $1.60 | $16,968.00 |
DisclosureSEC source: 0001593968-21-001114 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:02 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 395 | $49.73 | $19,644.69 |
DisclosureSEC source: 0001593968-21-001114 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,616 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $48.81 to $50.30. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.